Compare peptides side by side
Pick two to four compounds and see them side by side: evidence grade, legal status, what each is sold for and a one-line summary.
Loading the compound list.
Common comparisons
- Semaglutide, tirzepatide and retatrutide
- BPC-157, TB-500 and GHK-Cu
- Sermorelin, ipamorelin, CJC-1295 and tesamorelin
- Semax and Selank
- NAD+, MOTS-c and Epitalon
How to read it
- The grade is about evidence. It describes how strong the human research is for a compound's best-studied use. It is not a verdict on safety or legality.
- "Sold for" is how a compound is marketed, not what it has been shown to do. The one-line summary says what was actually tested.
- This table shows the short facts only. Each compound's full page has the trial results, dosing sources and safety information. For two pairs we have written a deeper comparison: semaglutide vs tirzepatide and BPC-157 vs TB-500.
Nothing you select is saved or sent anywhere. General information, not medical advice.